25 XP 0   0   10  
0coffee
Main menu
3rd party ad coffee SUPPORTERis ad-free.

OKYO (OKYO Pharma Ltd ADR) Stock Analysis
Buy, Hold or Sell?

Let's analyze OKYO Pharma Ltd ADR together

I guess you are interested in OKYO Pharma Ltd ADR. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

  • 📊 Fundamental Analysis (FA) – OKYO Pharma Ltd ADR’s Financial Insights
  • 📈 Technical Analysis (TA) – OKYO Pharma Ltd ADR’s Price Targets

I'm going to help you getting a better view of OKYO Pharma Ltd ADR. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

Get notifications about OKYO Pharma Ltd ADR

I send you an email if I find something interesting about OKYO Pharma Ltd ADR.

1. Quick Overview

1.1. Quick analysis of OKYO Pharma Ltd ADR (30 sec.)










1.2. What can you expect buying and holding a share of OKYO Pharma Ltd ADR? (30 sec.)

How much money do you get?

How much money do you get?
$0.00
When do you have the money?
1 year
How often do you get paid?
2.5%

What is your share worth?

Current worth
$-0.15
Expected worth in 1 year
$-0.10
How sure are you?
40.0%

+ What do you gain per year?

Total Gains per Share
$0.04
Return On Investment
1.9%

For what price can you sell your share?

Current Price per Share
$2.39
Expected price per share
$1.74 - $3.349
How sure are you?
50%
3rd party ad coffee SUPPORTERis ad-free.

2. Detailed Analysis

2.1. Valuation of OKYO Pharma Ltd ADR (5 min.)




Live pricePrice per Share (EOD)
$2.39
Intrinsic Value Per Share
$-2.19 - $-0.96
Total Value Per Share
$-2.34 - $-1.11

2.2. Growth of OKYO Pharma Ltd ADR (5 min.)




Is OKYO Pharma Ltd ADR growing?

Current yearPrevious yearGrowGrow %
How rich?-$5.5m-$3.9m-$2m-33.7%

How much money is OKYO Pharma Ltd ADR making?

Current yearPrevious yearGrowGrow %
Making money-$1.6m-$5.5k-$1.6m-99.7%
Net Profit Margin0.0%0.0%--

How much money comes from the company's main activities?

2.3. Financial Health of OKYO Pharma Ltd ADR (5 min.)




2.4. Comparing to competitors in the Biotechnology industry (5 min.)




  Industry Rankings (Biotechnology)  


Richest
#775 / 849

Most Revenue
#710 / 849

Most Profit
#284 / 849

Most Efficient
#241 / 849
3rd party ad coffee SUPPORTERis ad-free.

3. Summary and Key Metrics

3.1. What can you expect buying and holding a share of OKYO Pharma Ltd ADR?

Welcome investor! OKYO Pharma Ltd ADR's management wants to use your money to grow the business. In return you get a share of OKYO Pharma Ltd ADR.

First you should know what it really means to hold a share of OKYO Pharma Ltd ADR. And how you can make/lose money.

Speculation

The Price per Share of OKYO Pharma Ltd ADR is $2.39. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of OKYO Pharma Ltd ADR.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in OKYO Pharma Ltd ADR, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is $-0.15. Based on the TTM, the Book Value Change Per Share is $0.01 per quarter. Based on the YOY, the Book Value Change Per Share is $-0.07 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is $0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of OKYO Pharma Ltd ADR.

How much money are you going to get?

 MRQTTMYOY3Y5Y10Y
 $% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share
Usd Eps-0.05-2.3%-0.04-1.8%0.000.0%-0.02-0.8%-0.02-1.0%-0.01-0.6%
Usd Book Value Change Per Share-0.01-0.3%0.010.5%-0.07-2.9%-0.01-0.5%-0.01-0.3%-0.01-0.3%
Usd Dividend Per Share0.000.0%0.000.0%0.000.0%0.010.6%0.010.4%0.000.2%
Usd Total Gains Per Share-0.01-0.3%0.010.5%-0.07-2.9%0.000.1%0.000.0%0.00-0.1%
Usd Price Per Share2.57-1.50-1.58-1.64-1.09-0.54-
Price to Earnings Ratio-11.92--2,673.77--4,058.80--3,002.50--1,801.93--900.97-
Price-to-Total Gains Ratio-366.32--53.16--20.31--330.17--299.58--299.58-
Price to Book Ratio-17.42--9.89--1.24--32.50--32.25--16.12-
Price-to-Total Gains Ratio-366.32--53.16--20.31--330.17--299.58--299.58-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share2.39
Number of shares418
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.01
Usd Book Value Change Per Share0.01-0.01
Usd Total Gains Per Share0.010.00
Gains per Quarter (418 shares)4.660.45
Gains per Year (418 shares)18.631.82
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
1019914-12-8
20372828-25-6
30564742-37-4
40756656-49-2
50938570-610
6011210485-742
7013012399-864
80149142113-986
90168161127-1108
100186180141-12310

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share0.04.00.00.0%0.012.00.00.0%0.020.00.00.0%1.039.00.02.5%9.061.00.012.9%
Book Value Change Per Share2.01.01.050.0%3.06.03.025.0%7.010.03.035.0%15.022.03.037.5%27.032.011.038.6%
Dividend per Share0.00.04.00.0%1.00.011.08.3%1.00.019.05.0%1.00.039.02.5%5.00.065.07.1%
Total Gains per Share2.01.01.050.0%4.05.03.033.3%8.09.03.040.0%16.021.03.040.0%30.031.09.042.9%
3rd party ad coffee SUPPORTERis ad-free.

3.2. Key Performance Indicators

The key performance indicators of OKYO Pharma Ltd ADR compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-3Y+/-5 Year+/-10 Year+/-
Book Value Change Per Share---0.0070.011-163%-0.069+883%-0.012+65%-0.007+5%-0.007+7%
Book Value Per Share---0.148-0.157+6%-0.105-29%-0.089-39%-0.025-83%0.089-265%
Current Ratio--0.3980.369+8%0.174+129%0.416-4%2.448-84%10.417-96%
Debt To Asset Ratio--2.5092.770-9%3.395-26%2.420+4%1.635+53%0.965+160%
Debt To Equity Ratio----0%-0%-0%0.083-100%0.149-100%
Dividend Per Share----0%-0%0.014-100%0.008-100%0.004-100%
Enterprise Value--88993448.32049088917.573+81%54171028.950+64%57065910.126+56%58654487.239+52%58654487.239+52%
Eps---0.054-0.044-18%0.000-100%-0.020-63%-0.025-54%-0.013-75%
Ev To Ebitda Ratio---5.931-2284.991+38428%-3358.643+56531%-2999.684+50478%-3308.145+55679%-3308.145+55679%
Free Cash Flow Per Share---0.042-0.022-47%0.000-100%-0.007-82%-0.014-67%-0.008-81%
Free Cash Flow To Equity Per Share--0.0140.009+58%0.000+100%0.003+374%0.005+174%0.002+606%
Gross Profit Margin--1.0001.0000%1.0000%1.099-9%1.059-6%1.074-7%
Intrinsic Value_10Y_max---0.958----------
Intrinsic Value_10Y_min---2.188----------
Intrinsic Value_1Y_max---0.039----------
Intrinsic Value_1Y_min---0.065----------
Intrinsic Value_3Y_max---0.161----------
Intrinsic Value_3Y_min---0.329----------
Intrinsic Value_5Y_max---0.335----------
Intrinsic Value_5Y_min---0.740----------
Market Cap89889515.640-8%96659437.32057105232.073+69%59236814.700+63%61867368.876+56%41069542.305+135%20534771.153+371%
Net Profit Margin----0%-0%-0%-0%0.007-100%
Operating Margin----0%-0%-0%-0%0.004-100%
Operating Ratio----0%-0%-0%-0%0.024-100%
Pb Ratio-16.198+7%-17.418-9.889-43%-1.241-93%-32.495+87%-32.250+85%-16.125-7%
Pe Ratio-11.089+7%-11.925-2673.766+22322%-4058.796+33937%-3002.496+25079%-1801.931+15011%-900.966+7456%
Price Per Share2.390-8%2.5701.502+71%1.575+63%1.640+57%1.089+136%0.544+372%
Price To Free Cash Flow Ratio-14.306+7%-15.384-3459.123+22386%-28336.678+184098%-12598.267+81793%-8238.433+53453%-4119.216+26676%
Price To Total Gains Ratio-340.659+7%-366.316-53.164-85%-20.311-94%-330.173-10%-299.581-18%-299.581-18%
Quick Ratio--0.3740.291+28%0.114+227%0.371+1%2.369-84%12.840-97%
Return On Assets---0.551-0.512-7%-0.002-100%-0.172-69%-0.198-64%-0.162-71%
Return On Equity----0%-0%-0%-0.1320%-0.0670%
Total Gains Per Share---0.0070.011-163%-0.069+883%0.002-388%0.001-746%-0.003-53%
Usd Book Value---5549555.000-5968574.250+8%-3958528.250-29%-3387938.333-39%-939165.538-83%3353713.881-265%
Usd Book Value Change Per Share---0.0070.011-163%-0.069+883%-0.012+65%-0.007+5%-0.007+7%
Usd Book Value Per Share---0.148-0.157+6%-0.105-29%-0.089-39%-0.025-83%0.089-265%
Usd Dividend Per Share----0%-0%0.014-100%0.008-100%0.004-100%
Usd Enterprise Value--88993448.32049088917.573+81%54171028.950+64%57065910.126+56%58654487.239+52%58654487.239+52%
Usd Eps---0.054-0.044-18%0.000-100%-0.020-63%-0.025-54%-0.013-75%
Usd Free Cash Flow---1570800.000-846157.500-46%-2739.218-100%-284015.743-82%-522504.545-67%-307938.326-80%
Usd Free Cash Flow Per Share---0.042-0.022-47%0.000-100%-0.007-82%-0.014-67%-0.008-81%
Usd Free Cash Flow To Equity Per Share--0.0140.009+58%0.000+100%0.003+374%0.005+174%0.002+606%
Usd Market Cap89889515.640-8%96659437.32057105232.073+69%59236814.700+63%61867368.876+56%41069542.305+135%20534771.153+371%
Usd Price Per Share2.390-8%2.5701.502+71%1.575+63%1.640+57%1.089+136%0.544+372%
Usd Profit---2026474.000-1683444.750-17%-5542.103-100%-564715.487-72%-825257.839-59%-451654.466-78%
Usd Revenue----0%-0%-0%-0%4.456-100%
Usd Total Gains Per Share---0.0070.011-163%-0.069+883%0.002-388%0.001-746%-0.003-53%
 EOD+2 -6MRQTTM+15 -15YOY+16 -143Y+11 -225Y+11 -2310Y+13 -25

3.3 Fundamental Score

Let's check the fundamental score of OKYO Pharma Ltd ADR based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-11.089
Price to Book Ratio (EOD)Between0-1-16.198
Net Profit Margin (MRQ)Greater than00.000
Operating Margin (MRQ)Greater than00.000
Quick Ratio (MRQ)Greater than10.374
Current Ratio (MRQ)Greater than10.398
Debt to Asset Ratio (MRQ)Less than12.509
Debt to Equity Ratio (MRQ)Less than10.000
Return on Equity (MRQ)Greater than0.150.000
Return on Assets (MRQ)Greater than0.05-0.551
Total1/10 (10.0%)

3.4 Technical Score

Let's check the technical score of OKYO Pharma Ltd ADR based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5058.276
Ma 20Greater thanMa 502.117
Ma 50Greater thanMa 1002.198
Ma 100Greater thanMa 2002.428
OpenGreater thanClose2.280
Total2/5 (40.0%)

4. In-depth Analysis

4.1 About OKYO Pharma Ltd ADR

OKYO Pharma Limited, a clinical-stage biopharmaceutical company, develops therapeutics for patients suffering from inflammatory eye diseases and ocular pain in the United Kingdom. Its lead clinical product candidate is urcosimod, which is in Phase II clinical trials for the treatment of dry eye disease; in Phase II clinical trial to treat neuropathic corneal pain; and is in preclinical trial to treat allergic conjunctivitis and uveitis. The company is also developing OK-201 for the treatment acute and chronic ocular pain. OKYO Pharma Limited was incorporated in 2007 and is headquartered in London, the United Kingdom.

Fundamental data was last updated by Penke on 2025-10-15 12:58:05.

4.2 In-depth Summary

4.2.1. Financial Health Summary

Profitability Details
 Compared to previous yearCompared to industry
Using its assets, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
Liquidity Details
 Compared to previous yearCompared to industry
The company is unable to pay all its short-term debts.
The company is just not able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is unable to pay all its debts by selling its assets.

4.2.2. Valuation Summary

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is expensive.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is expensive.
3rd party ad coffee SUPPORTERis ad-free.

4.3 Financial Health

4.3.1. Profitability

4.3.1 Profitability
4.3.1.1. Net Profit Margin

Measures how much net profit OKYO Pharma Ltd ADR earns for each $1 of revenue.

  • Above 10% is considered healthy but always compare OKYO Pharma Ltd ADR to the Biotechnology industry mean.
  • A Net Profit Margin of 0.0% means that $0.00 for each $1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of OKYO Pharma Ltd ADR:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY-0.0%
TTM-5Y-0.0%
5Y-10Y0.7%-0.7%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ--77.6%+77.6%
TTM--167.4%+167.4%
YOY--186.4%+186.4%
3Y--263.9%+263.9%
5Y--345.5%+345.5%
10Y0.7%-477.5%+478.2%
4.3.1.2. Return on Assets

Shows how efficient OKYO Pharma Ltd ADR is using its assets to generate profit.

  • Above 5% is considered healthy but always compare OKYO Pharma Ltd ADR to the Biotechnology industry mean.
  • -55.1% Return on Assets means that OKYO Pharma Ltd ADR generated $-0.55 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of OKYO Pharma Ltd ADR:

  • The MRQ is -55.1%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -51.2%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-55.1%TTM-51.2%-3.9%
TTM-51.2%YOY-0.2%-51.0%
TTM-51.2%5Y-19.8%-31.4%
5Y-19.8%10Y-16.2%-3.6%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-55.1%-12.0%-43.1%
TTM-51.2%-11.9%-39.3%
YOY-0.2%-11.0%+10.8%
3Y-17.2%-12.0%-5.2%
5Y-19.8%-11.7%-8.1%
10Y-16.2%-13.8%-2.4%
4.3.1.3. Return on Equity

Shows how efficient OKYO Pharma Ltd ADR is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare OKYO Pharma Ltd ADR to the Biotechnology industry mean.
  • 0.0% Return on Equity means OKYO Pharma Ltd ADR generated $0.00 for each $1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of OKYO Pharma Ltd ADR:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY-0.0%
TTM-5Y-13.2%+13.2%
5Y-13.2%10Y-6.7%-6.6%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ--14.2%+14.2%
TTM--14.8%+14.8%
YOY--15.0%+15.0%
3Y--16.6%+16.6%
5Y-13.2%-16.9%+3.7%
10Y-6.7%-19.5%+12.8%
3rd party ad coffee SUPPORTERis ad-free.

4.3.2. Operating Efficiency of OKYO Pharma Ltd ADR.

4.3.2. Operating Efficiency
4.3.2.1. Operating Margin

Measures how efficient OKYO Pharma Ltd ADR is operating .

  • Measures how much profit OKYO Pharma Ltd ADR makes for each $1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare OKYO Pharma Ltd ADR to the Biotechnology industry mean.
  • An Operating Margin of 0.0% means the company generated $0.00  for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of OKYO Pharma Ltd ADR:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY-0.0%
TTM-5Y-0.0%
5Y-10Y0.4%-0.4%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ--155.0%+155.0%
TTM--266.6%+266.6%
YOY--246.9%+246.9%
3Y--248.8%+248.8%
5Y--338.0%+338.0%
10Y0.4%-498.1%+498.5%
4.3.2.2. Operating Ratio

Measures how efficient OKYO Pharma Ltd ADR is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Biotechnology industry mean).
  • An Operation Ratio of 0.00 means that the operating costs are $0.00 for each $1 in net sales.

Let's take a look of the Operating Ratio trends of OKYO Pharma Ltd ADR:

  • The MRQ is 0.000. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.000
TTM-YOY-0.000
TTM-5Y-0.000
5Y-10Y0.024-0.024
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-1.873-1.873
TTM-2.793-2.793
YOY-2.820-2.820
3Y-3.575-3.575
5Y-4.664-4.664
10Y0.0246.406-6.382
3rd party ad coffee SUPPORTERis ad-free.

4.4.3. Liquidity of OKYO Pharma Ltd ADR.

4.4.3. Liquidity
4.4.3.1. Current Ratio

Measures if OKYO Pharma Ltd ADR is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Biotechnology industry mean).
  • A Current Ratio of 0.40 means the company has $0.40 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of OKYO Pharma Ltd ADR:

  • The MRQ is 0.398. The company is unable to pay all its short-term debts. -2
  • The TTM is 0.369. The company is unable to pay all its short-term debts. -2
Trends
Current periodCompared to+/- 
MRQ0.398TTM0.369+0.029
TTM0.369YOY0.174+0.195
TTM0.3695Y2.448-2.079
5Y2.44810Y10.417-7.969
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.3983.414-3.016
TTM0.3693.605-3.236
YOY0.1744.036-3.862
3Y0.4164.431-4.015
5Y2.4485.716-3.268
10Y10.4176.128+4.289
4.4.3.2. Quick Ratio

Measures if OKYO Pharma Ltd ADR is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare OKYO Pharma Ltd ADR to the Biotechnology industry mean.
  • A Quick Ratio of 0.37 means the company can pay off $0.37 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of OKYO Pharma Ltd ADR:

  • The MRQ is 0.374. The company is just not able to pay all its short-term debts with the most liquid assets. -1
  • The TTM is 0.291. The company is just not able to pay all its short-term debts with the most liquid assets. -1
Trends
Current periodCompared to+/- 
MRQ0.374TTM0.291+0.082
TTM0.291YOY0.114+0.177
TTM0.2915Y2.369-2.078
5Y2.36910Y12.840-10.471
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.3742.910-2.536
TTM0.2913.142-2.851
YOY0.1143.825-3.711
3Y0.3714.359-3.988
5Y2.3695.692-3.323
10Y12.8406.524+6.316
3rd party ad coffee SUPPORTERis ad-free.

4.5.4. Solvency of OKYO Pharma Ltd ADR.

4.5.4. Solvency
4.5.4.1. Debt to Asset Ratio

Measures how much % of OKYO Pharma Ltd ADR assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare OKYO Pharma Ltd ADR to Biotechnology industry mean.
  • A Debt to Asset Ratio of 2.51 means that OKYO Pharma Ltd ADR assets are financed with 250.9% credit (debt) and the remaining percentage (100% - 250.9%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of OKYO Pharma Ltd ADR:

  • The MRQ is 2.509. The company is unable to pay all its debts by selling its assets. -2
  • The TTM is 2.770. The company is unable to pay all its debts by selling its assets. -2
Trends
Current periodCompared to+/- 
MRQ2.509TTM2.770-0.261
TTM2.770YOY3.395-0.624
TTM2.7705Y1.635+1.135
5Y1.63510Y0.965+0.671
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ2.5090.342+2.167
TTM2.7700.360+2.410
YOY3.3950.331+3.064
3Y2.4200.344+2.076
5Y1.6350.348+1.287
10Y0.9650.378+0.587
4.5.4.2. Debt to Equity Ratio

Measures if OKYO Pharma Ltd ADR is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare OKYO Pharma Ltd ADR to the Biotechnology industry mean.
  • A Debt to Equity ratio of 0.0% means that company has $0.00 debt for each $1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of OKYO Pharma Ltd ADR:

  • The MRQ is 0.000. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.000
TTM-YOY-0.000
TTM-5Y0.083-0.083
5Y0.08310Y0.149-0.066
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-0.399-0.399
TTM-0.439-0.439
YOY-0.429-0.429
3Y-0.471-0.471
5Y0.0830.471-0.388
10Y0.1490.518-0.369
3rd party ad coffee SUPPORTERis ad-free.

4.6. Market Valuation

4.6.1. Earnings Per Share
4.6.2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every $1 in earnings OKYO Pharma Ltd ADR generates.

  • Above 15 is considered overpriced but always compare OKYO Pharma Ltd ADR to the Biotechnology industry mean.
  • A PE ratio of -11.92 means the investor is paying $-11.92 for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of OKYO Pharma Ltd ADR:

  • The EOD is -11.089. Based on the earnings, the company is expensive. -2
  • The MRQ is -11.925. Based on the earnings, the company is expensive. -2
  • The TTM is -2,673.766. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-11.089MRQ-11.925+0.835
MRQ-11.925TTM-2,673.766+2,661.842
TTM-2,673.766YOY-4,058.796+1,385.030
TTM-2,673.7665Y-1,801.931-871.835
5Y-1,801.93110Y-900.966-900.966
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-11.089-2.850-8.239
MRQ-11.925-2.296-9.629
TTM-2,673.766-2.701-2,671.065
YOY-4,058.796-3.622-4,055.174
3Y-3,002.496-3.843-2,998.653
5Y-1,801.931-6.007-1,795.924
10Y-900.966-6.977-893.989
4.6.2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of OKYO Pharma Ltd ADR:

  • The EOD is -14.306. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -15.384. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is -3,459.123. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-14.306MRQ-15.384+1.077
MRQ-15.384TTM-3,459.123+3,443.740
TTM-3,459.123YOY-28,336.678+24,877.554
TTM-3,459.1235Y-8,238.433+4,779.309
5Y-8,238.43310Y-4,119.216-4,119.216
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-14.306-3.583-10.723
MRQ-15.384-2.921-12.463
TTM-3,459.123-3.869-3,455.254
YOY-28,336.678-4.296-28,332.382
3Y-12,598.267-5.305-12,592.962
5Y-8,238.433-8.442-8,229.991
10Y-4,119.216-9.974-4,109.242
3rd party ad coffee SUPPORTERis ad-free.
4.6.2. Book Value per Share
4.6.2.1. Price to Book Ratio

Measures if the stock price of OKYO Pharma Ltd ADR is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Biotechnology industry mean).
  • A PB ratio of -17.42 means the investor is paying $-17.42 for each $1 in book value.

Let's take a look of the Price to Book Ratio trends of OKYO Pharma Ltd ADR:

  • The EOD is -16.198. Based on the equity, the company is expensive. -2
  • The MRQ is -17.418. Based on the equity, the company is expensive. -2
  • The TTM is -9.889. Based on the equity, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-16.198MRQ-17.418+1.220
MRQ-17.418TTM-9.889-7.528
TTM-9.889YOY-1.241-8.648
TTM-9.8895Y-32.250+22.360
5Y-32.25010Y-16.125-16.125
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-16.1982.506-18.704
MRQ-17.4182.062-19.480
TTM-9.8892.248-12.137
YOY-1.2412.465-3.706
3Y-32.4952.704-35.199
5Y-32.2503.833-36.083
10Y-16.1254.581-20.706
4.6.2. Total Gains per Share

4.7 Holders & Insider Transactions

Let's take a look at which institutions, funds and insiders are holding shares of OKYO Pharma Ltd ADR.

4.8.1. Institutions holding OKYO Pharma Ltd ADR

Institutions are holding 7.367% of the shares of OKYO Pharma Ltd ADR.

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2025-06-30Dauntless Investment Group, LLC7.27392.4129273578074700037.5607
2025-06-30HPM Partners LLC0.03410.00011281200
2025-06-30Geode Capital Management, LLC0.032101209000
2025-06-30Wealth Enhancement Advisory Services, LLC0.02660.000110000100000
2025-06-30UBS Group AG0.000301151150
2025-06-30Renaissance Technologies Corp000-13946-100
2025-06-30FNY Investment Advisers, LLC000-20000-100
2025-06-30Continuum Advisory, LLC000-50-100
2025-03-31Barclays PLC000-961000-100
2025-06-30Citadel Advisors Llc000-27404-100
Total 7.3672.41312770797-265285-9.6%

4.9.2. Funds holding OKYO Pharma Ltd ADR

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2025-07-31Fidelity Nasdaq Composite Index0.03210.00021209000
Total 0.03210.00021209000.0%

5.3. Insider Transactions

Insiders are holding 33.312% of the shares of OKYO Pharma Ltd ADR.

DateOwnerTypeAmountPricePost Transaction AmountLink
2023-09-15John P BrancaccioBUY166701.5
3rd party ad coffee SUPPORTERis ad-free.

5. Financial Statements




5.1. Latest Balance Sheet

Balance Sheet of 2025-06-30. Currency in USD. All numbers in thousands.

Summary
Total Assets3,677
Total Liabilities9,227
Total Stockholder Equity-5,550
 As reported
Total Liabilities 9,227
Total Stockholder Equity+ -5,550
Total Assets = 3,677

Assets

Total Assets3,677
Total Current Assets3,675
Long-term Assets2
Total Current Assets
Cash And Cash Equivalents 1,561
Net Receivables 1,889
Other Current Assets 225
Total Current Assets  (as reported)3,675
Total Current Assets  (calculated)3,675
+/-0
Long-term Assets
Property Plant Equipment 2
Long-term Assets  (as reported)2
Long-term Assets  (calculated)2
+/-0

Liabilities & Shareholders' Equity

Total Current Liabilities9,227
Long-term Liabilities-
Total Stockholder Equity-5,550
Total Current Liabilities
Accounts payable 7,900
Other Current Liabilities 1,327
Total Current Liabilities  (as reported)9,227
Total Current Liabilities  (calculated)9,227
+/-0
Long-term Liabilities
Long-term Liabilities  (as reported)0
Long-term Liabilities  (calculated)0
+/-0
Total Stockholder Equity
Common Stock146,717
Retained Earnings -143,025
Accumulated Other Comprehensive Income -11,470
Total Stockholder Equity (as reported)-5,550
Total Stockholder Equity (calculated)-7,778
+/- 2,229
Other
Cash and Short Term Investments 1,561
Common Stock Shares Outstanding 36,021
Liabilities and Stockholders Equity 3,677
Net Debt -1,561



5.2. Balance Sheets Structured

Currency in USD. All numbers in thousands.

 Trend2025-06-302025-03-312024-12-312024-09-302024-06-302024-03-312023-12-312023-09-302023-06-302023-03-312022-12-312022-09-302022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-12-312013-09-302013-06-302013-03-312012-12-312012-09-302012-06-302012-03-312011-12-312011-09-302011-06-302011-03-312010-12-312010-09-302010-06-302010-03-312009-12-312009-09-302009-06-302009-03-312008-12-312008-09-302008-06-302008-03-31
> Total Assets 
3,478
3,478
3,478
3,478
6,678
6,678
6,678
6,678
54,133
8,980
15,798
8,980
16,091
2,503
2,503
2,503
42,197
6,589
49,379
6,589
45,199
7,437
37,874
7,437
47,210
7,091
45,083
7,091
34,047
5,748
34,353
5,748
32,184
5,599
29,172
5,599
22,246
5,562
3,854
5,562
2,008
502
1,641
502
760
146
617
146
597
121
7,513
121
7,091
1,285
5,608
1,285
4,301
1,589
1,774
4,305
5,204
5,204
0
1,541
1,541
2,829
2,829
3,677
3,677
3,677
3,6773,6773,6772,8292,8291,5411,54105,2045,2044,3051,7741,5894,3011,2855,6081,2857,0911217,5131215971466171467605021,6415022,0085,5623,8545,56222,2465,59929,1725,59932,1845,74834,3535,74834,0477,09145,0837,09147,2107,43737,8747,43745,1996,58949,3796,58942,1972,5032,5032,50316,0918,98015,7988,98054,1336,6786,6786,6786,6783,4783,4783,4783,478
   > Total Current Assets 
2,273
2,273
2,273
2,273
5,348
5,348
5,348
5,348
54,133
8,980
15,798
8,980
16,091
2,503
2,503
2,503
17,470
2,728
21,288
2,728
14,575
2,398
5,967
2,398
12,186
1,830
9,071
1,830
6,792
1,147
6,297
1,147
5,371
934
4,727
934
16,858
822
3,797
822
0
502
1,641
502
759
145
616
145
567
115
7,483
115
6,987
1,266
5,523
1,266
4,295
1,584
1,769
4,299
5,197
4,045
4,045
1,538
1,538
2,827
2,827
3,675
3,675
3,675
3,6753,6753,6752,8272,8271,5381,5384,0454,0455,1974,2991,7691,5844,2951,2665,5231,2666,9871157,4831155671456161457595021,64150208223,79782216,8589344,7279345,3711,1476,2971,1476,7921,8309,0711,83012,1862,3985,9672,39814,5752,72821,2882,72817,4702,5032,5032,50316,0918,98015,7988,98054,1335,3485,3485,3485,3482,2732,2732,2732,273
       Cash And Cash Equivalents 
2,264
2,264
2,264
2,264
940
940
940
940
26,640
4,419
15,780
4,419
16,072
2,500
2,500
2,500
17,034
2,660
20,882
2,660
14,339
2,359
5,676
2,359
11,824
1,776
8,685
1,776
6,465
1,091
5,973
1,091
5,129
892
4,487
892
3,146
786
3,572
786
2,008
502
1,621
502
628
120
67
120
235
47
7,412
47
6,889
1,248
5,169
1,248
2,701
634
708
3,346
4,045
4,045
0
827
827
987
987
1,561
1,561
1,561
1,5611,5611,56198798782782704,0454,0453,3467086342,7011,2485,1691,2486,889477,41247235120671206285021,6215022,0087863,5727863,1468924,4878925,1291,0915,9731,0916,4651,7768,6851,77611,8242,3595,6762,35914,3392,66020,8822,66017,0342,5002,5002,50016,0724,41915,7804,41926,6409409409409402,2642,2642,2642,264
       Short-term Investments 
0
0
0
0
4,407
4,407
4,407
4,407
27,485
4,560
0
4,560
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
16,858
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
4,407
0
0
0
0
0
0
0
0
0
0000000004,4070000000000000000000000016,8580000000000000000000000004,56004,56027,4854,4074,4074,4074,4070000
       Net Receivables 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
2
22
152
22
261
39
156
39
160
40
137
40
12
28
124
28
123
31
8
31
0
0
21
0
85
21
422
21
263
66
39
66
55
14
235
14
673
883
-165
168
980
980
0
0
581
581
1,516
0
1,889
1,889
1,8891,88901,51658158100980980168-1658836731423514556639662632142221850210031831123281242812401374016039156392612215222200000000000000000000
       Other Current Assets 
9
9
9
9
2
2
2
2
8
1
18
1
19
3
3
3
369
68
337
68
254
17
140
17
257
15
386
15
250
15
106
15
180
14
203
14
19
5
172
5
0
0
16
0
105
4
549
4
269
1
71
1
97
4
276
4
711
950
1,037
952
171
171
0
711
130
1,840
324
2,114
225
225
2252252,1143241,84013071101711719521,037950711427649717112694549410501600517251914203141801510615250153861525717140172546833768369333191181822229999
   > Long-term Assets 
1,205
1,205
1,205
1,205
1,330
1,330
1,330
1,330
26,640
4,419
0
4,419
16,072
2,500
2,500
2,500
24,727
3,861
28,091
3,861
30,624
5,039
31,907
5,039
35,024
5,260
36,012
5,260
27,256
4,601
28,056
4,601
26,813
4,664
24,445
4,664
18,959
4,740
57
4,740
0
0
0
0
1
0
1
0
31
6
30
6
105
19
86
19
5
5
6
6
7
-4,045
-4,045
3
3
2
2
2
2
2
2222233-4,045-4,04576655198619105630631010100004,740574,74018,9594,66424,4454,66426,8134,60128,0564,60127,2565,26036,0125,26035,0245,03931,9075,03930,6243,86128,0913,86124,7272,5002,5002,50016,0724,41904,41926,6401,3301,3301,3301,3301,2051,2051,2051,205
       Property Plant Equipment 
1,205
1,205
1,205
1,205
1,205
1,205
1,205
1,205
0
0
0
0
0
0
0
0
4,464
77
26,706
77
11,394
1,875
16,873
1,875
19,545
2,936
20,909
2,936
17,314
2,923
17,882
2,923
17,165
2,986
15,696
2,986
12,245
3,061
57
3,061
0
0
0
0
1
0
1
0
31
6
30
6
105
19
86
19
5
5
6
6
7
7
0
3
3
2
2
2
2
2
22222330776655198619105630631010100003,061573,06112,2452,98615,6962,98617,1652,92317,8822,92317,3142,93620,9092,93619,5451,87516,8731,87511,3947726,706774,464000000001,2051,2051,2051,2051,2051,2051,2051,205
       Goodwill 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1,374
0
0
0
1,304
215
1,041
215
1,071
161
1,045
161
635
107
650
107
617
107
559
107
429
107
0
107
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
215
0
0
0
0
0
0
0
0
0
0000000002150000000000000000000010701074291075591076171076501076351611,0451611,0712151,0412151,3040001,3740000000000000000
       Intangible Assets 
0
0
0
0
125
125
125
125
0
0
0
0
0
0
0
0
18,889
3,785
0
3,785
17,926
2,950
13,993
2,950
14,408
2,164
14,058
2,164
9,306
1,571
9,524
1,571
9,032
1,571
8,189
1,571
6,285
1,571
0
1,571
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
125
0
0
0
0
0
0
0
0
0
000000000125000000000000000000001,57101,5716,2851,5718,1891,5719,0321,5719,5241,5719,3062,16414,0582,16414,4082,95013,9932,95017,9263,78503,78518,889000000001251251251250000
       Other Assets 
0
0
0
0
0
0
0
0
-26,640
-4,419
0
-4,419
-16,072
-2,500
-2,500
-2,500
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
000000000000000000000000000000000000000000000000000000-2,500-2,500-2,500-16,072-4,4190-4,419-26,64000000000
> Total Liabilities 
18
18
18
18
15
15
15
15
80
13
40
13
79
12
12
12
833
130
484
130
183
30
76
30
248
37
320
37
151
26
222
26
181
32
223
32
207
52
316
52
91
23
218
23
427
82
813
82
737
149
441
149
1,772
321
664
321
1,353
1,899
2,120
6,003
7,257
2,053
2,053
7,421
7,421
10,054
10,054
9,227
9,227
9,227
9,2279,2279,22710,05410,0547,4217,4212,0532,0537,2576,0032,1201,8991,3533216643211,7721494411497378281382427232182391523165220732223321812622226151373203724830763018313048413083312121279134013801515151518181818
   > Total Current Liabilities 
18
18
18
18
15
15
15
15
80
13
40
13
79
12
12
12
833
130
484
130
183
30
76
30
248
37
320
37
151
26
222
26
181
32
224
32
207
52
316
52
91
23
218
23
427
82
813
82
711
144
417
144
1,707
309
617
309
1,353
1,899
2,120
6,003
7,257
7,257
0
7,421
7,421
10,054
10,054
9,227
9,227
9,227
9,2279,2279,22710,05410,0547,4217,42107,2577,2576,0032,1201,8991,3533096173091,7071444171447118281382427232182391523165220732224321812622226151373203724830763018313048413083312121279134013801515151518181818
       Short-term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
4
0
5
0
34
0
34
0
0
0
0
-363
1,796
1,796
0
0
0
2
2
0
0
0
000220001,7961,796-3630000340340504000000000000000000000000000000000000000000000000
       Short Long Term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
2,215
0
0
0
0
0
2
0
0
0
0002000002,215000000000000000000000000000000000000000000000000000000000000
       Accounts payable 
18
18
18
18
15
15
15
15
80
13
0
13
42
7
7
7
493
77
85
77
74
12
21
12
123
18
287
18
120
20
217
20
124
22
171
22
142
37
292
37
0
0
90
0
382
73
779
73
594
120
213
120
211
38
216
38
518
1,364
1,238
1,975
1,024
1,024
0
6,128
6,128
9,607
9,607
7,900
7,900
7,900
7,9007,9007,9009,6079,6076,1286,12801,0241,0241,9751,2381,36451838216382111202131205947377973382090003729237142221712212420217201201828718123122112747785774937774213013801515151518181818
       Other Current Liabilities 
0
0
0
0
0
0
0
0
0
0
40
0
37
6
6
6
340
53
398
53
110
18
55
18
26
19
33
19
31
5
-71
5
57
10
52
10
75
15
-56
15
128
23
128
23
45
9
34
9
113
24
198
24
1,462
271
367
271
836
535
882
2,196
4,438
4,438
0
1,293
1,293
446
446
1,327
1,327
1,327
1,3271,3271,3274464461,2931,29304,4384,4382,1968825358362713672711,4622419824113934945231282312815-561575105210575-71531193319261855181105339853340666370400000000000
   > Long-term Liabilities 
18
18
18
18
15
15
15
15
53
13
0
13
26
7
7
7
308
77
53
77
48
12
32
12
74
18
177
18
81
20
143
20
86
22
-1
22
147
37
218
37
0
0
90
0
293
73
634
73
27
5
24
5
65
12
47
12
565
141
1,364
141
5
2,053
2,053
0
0
0
0
0
0
0
00000002,0532,05351411,36414156512471265524527736347329309000372183714722-12286201432081181771874123212487753773087772613013531515151518181818
> Total Stockholder Equity
3,459
3,459
3,459
3,459
6,663
6,663
6,663
6,663
54,053
8,967
15,758
8,967
16,012
2,491
2,491
2,491
41,341
6,459
48,895
6,459
45,016
7,407
37,798
7,407
46,962
7,053
44,762
7,053
33,896
5,723
34,131
5,723
32,003
5,567
28,949
5,567
22,039
5,510
3,538
5,510
1,917
479
1,423
479
333
64
-196
64
-140
-28
7,072
-28
5,319
964
4,944
964
2,947
-310
-346
-1,698
-2,053
-2,053
-2,053
-5,880
-5,880
-7,226
-7,226
-5,550
-5,550
-5,550
-5,550-5,550-5,550-7,226-7,226-5,880-5,880-2,053-2,053-2,053-1,698-346-3102,9479644,9449645,319-287,072-28-14064-196643334791,4234791,9175,5103,5385,51022,0395,56728,9495,56732,0035,72334,1315,72333,8967,05344,7627,05346,9627,40737,7987,40745,0166,45948,8956,45941,3412,4912,4912,49116,0128,96715,7588,96754,0536,6636,6636,6636,6633,4593,4593,4593,459
   Common Stock
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
90,596
0
96,704
0
65,954
16,488
0
16,488
98,018
0
100,308
0
95,124
16,548
0
16,548
66,192
16,548
88,676
16,548
66,368
16,592
86,471
16,592
89,218
17,101
84,573
17,101
67,519
16,880
86,363
16,880
111,629
0
102,543
0
123,977
123,977
87,847
23,595
131,386
131,386
0
0
143,113
143,113
144,050
0
146,717
146,717
146,717146,7170144,050143,113143,11300131,386131,38623,59587,847123,977123,9770102,5430111,62916,88086,36316,88067,51917,10184,57317,10189,21816,59286,47116,59266,36816,54888,67616,54866,19216,548016,54895,1240100,308098,01816,488016,48865,954096,704090,59600000000000000000000
   Retained Earnings 
-375
-375
-375
-375
2,127
2,127
2,127
2,127
28,964
4,805
-9,207
4,805
-9,542
-1,485
-1,485
-1,485
-29,647
-4,630
-48,721
-4,630
-48,159
-7,924
-61,520
-7,924
-66,005
-9,914
-64,332
-9,914
-65,920
-11,129
-67,992
-11,129
-64,712
-11,257
-58,803
-11,257
-44,354
-11,089
-85,124
-11,089
-64,451
-16,113
-85,528
-16,113
-88,966
-17,053
-84,933
-17,053
-85,878
-17,356
-90,555
-17,356
-106,004
-18,146
-99,968
-18,146
-112,426
-81,404
-90,904
-103,979
-125,698
-125,698
0
-142,523
-142,523
-145,202
-145,202
-143,024
-143,025
-143,025
-143,025-143,025-143,024-145,202-145,202-142,523-142,5230-125,698-125,698-103,979-90,904-81,404-112,426-18,146-99,968-18,146-106,004-17,356-90,555-17,356-85,878-17,053-84,933-17,053-88,966-16,113-85,528-16,113-64,451-11,089-85,124-11,089-44,354-11,257-58,803-11,257-64,712-11,129-67,992-11,129-65,920-9,914-64,332-9,914-66,005-7,924-61,520-7,924-48,159-4,630-48,721-4,630-29,647-1,485-1,485-1,485-9,5424,805-9,2074,80528,9642,1272,1272,1272,127-375-375-375-375
   Capital Surplus 0000000000000000000000000000000000000000000000000000000000000000000000
   Treasury Stock0000000000000000000000000000000000000000000000000000000000000000000000
   Other Stockholders Equity 
3,834
3,834
3,834
3,834
4,536
4,536
4,536
4,536
25,089
4,162
24,965
4,162
25,554
3,976
3,976
3,976
70,988
11,100
97,616
11,100
-12,810
15,374
-12,088
15,374
112,809
548
109,094
548
-9,208
16,962
-9,686
16,962
-7,867
830
87,752
830
-82,752
112
87,779
112
67,138
0
150
0
3
16
201
16
85,738
449
11,264
449
-306
19,110
2,369
19,110
2,408
78,667
2,769
108,684
3,711
3,711
0
143,113
4,842
144,049
144,049
146,716
146,716
146,716
146,716146,716146,716144,049144,0494,842143,11303,7113,711108,6842,76978,6672,40819,1102,36919,110-30644911,26444985,738162011630150067,13811287,779112-82,75283087,752830-7,86716,962-9,68616,962-9,208548109,094548112,80915,374-12,08815,374-12,81011,10097,61611,10070,9883,9763,9763,97625,5544,16224,9654,16225,0894,5364,5364,5364,5363,8343,8343,8343,834



5.3. Balance Sheets

Currency in USD. All numbers in thousands.




5.4. Cash Flows

Currency in USD. All numbers in thousands.




5.5. Income Statements

Currency in USD. All numbers in thousands.


5.6. Latest Income Statement

Income Statement (annual), 2025-03-31. Currency in USD. All numbers in thousands.

Gross Profit (+$)
totalRevenue0
Cost of Revenue-3
Gross Profit-3-3
 
Operating Income (+$)
Gross Profit-3
Operating Expense-7,186
Operating Income-7,189-7,189
 
Operating Expense (+$)
Research Development2,254
Selling General Administrative-
Selling And Marketing Expenses-
Operating Expense7,1862,254
 
Net Interest Income (+$)
Interest Income5
Interest Expense-884
Other Finance Cost-0
Net Interest Income-878
 
Pretax Income (+$)
Operating Income-7,189
Net Interest Income-878
Other Non-Operating Income Expenses-
Income Before Tax (EBT)-7,970-6,408
EBIT - interestExpense = -7,970
-7,970
-3,823
Interest Expense884
Earnings Before Interest and Taxes (EBIT)-7,086-7,086
Earnings Before Interest and Taxes (EBITDA)-7,084
 
After tax Income (+$)
Income Before Tax-7,970
Tax Provision--3,264
Net Income From Continuing Ops-4,706-4,706
Net Income-4,706
Net Income Applicable To Common Shares-
 
Non-recurring Events
Discontinued Operations-
Extraordinary Items-
Effect of Accounting Charges-
Other Items-
Non Recurring-
Other Operating Expenses7,189
Total Other Income/Expenses Net-781878
 

Technical Analysis of OKYO Pharma Ltd ADR
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of OKYO Pharma Ltd ADR. The general trend of OKYO Pharma Ltd ADR is BULLISH with 28.6% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine OKYO Pharma Ltd ADR's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (28.6%) Bearish trend (-28.6%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. OKYO Pharma Ltd ADR Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of OKYO Pharma Ltd ADR.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is -1/(-1 +1).

  • Around resistance: The price is trading arround resistance levels. This can be considered as a potential exit level. -1

The bullish price targets are: 2.45 < 2.46 < 3.349.

The bearish price targets are: 1.93 > 1.9036 > 1.74.

Know someone who trades $OKYO? Share this with them.👇

OKYO Pharma Ltd ADR Daily Support & Resistance Chart
3rd party ad coffee SUPPORTERis ad-free.

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of OKYO Pharma Ltd ADR. The current mas is .

The long score for the Moving Averages is 9/14.
The longshort score for the Moving Averages is 4/(-14 +14).

  • MA 20 trending up: The MA 20 is trending up. +1
  • Close > MA 20: The price is above the MA 20. +1
  • MA 20 < MA 50: The MA 20 is lower than the MA 50. -1
  • MA 20 < MA 100: The MA 20 is lower than the MA 100. -1
  • MA 20 > MA 200: The MA 20 is higher than the MA 200. +1
  • MA 50 trending down: The MA 50 is trending down. -1
  • Close > MA 50: The price is above the MA 50. +1
  • MA 50 < MA 100: The MA 50 is lower than the MA 100. -1
  • MA 50 > MA 200: The MA 50 is higher than the MA 200. +1
  • MA 100 trending up: The MA 100 is trending up. +1
  • Close < MA 100: The price is below the MA 100. -1
  • MA 100 > MA 200: The MA 100 is higher than the MA 200. +1
  • MA 200 trending up: The MA 200 is trending up. +1
  • Close > MA 200: The price is above the MA 200. +1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

OKYO Pharma Ltd ADR Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of OKYO Pharma Ltd ADR. The current macd is 0.02826742.

The long score for the Moving Average Convergence/Divergence (MACD) is 4/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is 4/(-4 +4).

  • MACD line > signal line: The MACD line is above the signal line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the OKYO Pharma Ltd ADR price going up in the near term. +2
  • MACD > 0: The MACD is above the zero line (centerline), it indicates a bullish signal for OKYO Pharma Ltd ADR. This means that the short-term moving average is higher than the long-term moving average, signaling positive momentum and suggesting a higher likelihood of the OKYO Pharma Ltd ADR price continuing to rise in the near future. It indicates that buyers are gaining control, and there is optimism in the market, leading to potential price increases. +1
  • Trending up: The MACD line is trending up. This indicates that the short-term moving average is rising faster than the long-term moving average, suggesting positive momentum in the market. This signals that buyers are becoming more active and confident, leading to potential price increases as traders anticipate further gains and are willing to buy at higher prices. +1
OKYO Pharma Ltd ADR Daily Moving Average Convergence/Divergence (MACD) ChartOKYO Pharma Ltd ADR Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of OKYO Pharma Ltd ADR. The current adx is 16.25.

The long score for the Directional Movement Index (DMI) is 2/7.
The longshort score for the Directional Movement Index (DMI) is 2/(-7 +7).

  • PLUS_ID > MINUS_DI: The +DI line is above the -DI line. This indicates a bullish signal in the market, as the positive directional movement is currently stronger than the negative directional movement, showing that buyers have the upper hand. Market psychology suggests that traders are optimistic, expecting further price increases, and are more willing to buy OKYO Pharma Ltd ADR shares, leading to potential upward momentum in its price. +1
  • PLUS_ID > MINUS_DI && ADX < 25 && ADX trending up: The ADX is below 25 and indicates a weak or no trend. However, the ADX is rising and a new bullish trend could be forming. +1
OKYO Pharma Ltd ADR Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of OKYO Pharma Ltd ADR. The current sar is 1.94757067.

The long score for the Parabolic SAR is 1/1.
The longshort score for the Parabolic SAR is 1/(-1 +1).

  • Close > SAR: The price is above the SAR. It's generally considered a bullish signal. +1
OKYO Pharma Ltd ADR Daily Parabolic SAR Chart
3rd party ad coffee SUPPORTERis ad-free.

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of OKYO Pharma Ltd ADR. The current rsi is 58.28. The current phase is Continuation in bull market.

The long score for the Relative Strength Index (RSI) is 4/13.
The longshort score for the Relative Strength Index (RSI) is 4/(-13 +13).

  • Continuation in bull market: Uptrend continues after a consolidation or pullback. Hold or add to existing positions.
  • Trending up: The RSI is trending up. +1
OKYO Pharma Ltd ADR Daily Relative Strength Index (RSI) ChartOKYO Pharma Ltd ADR Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of OKYO Pharma Ltd ADR. The current phase is Overbought in bull market.

The long score for the Stochastic Oscillator is 6/6.
The longshort score for the Stochastic Oscillator is 6/(-6 +6).

  • STOCH > 50: The STOCH %K is above 50. There are more buyers than sellers. +1
  • STOCH > 80: The STOCH %K is above 80 and overbought. +2
  • STOCH %K line > STOCH %D line: The STOCH %K line is above the STOCH %D line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the OKYO Pharma Ltd ADR price going up in the near term. +2
  • Trending up: The STOCH %K is trending up. +1
OKYO Pharma Ltd ADR Daily Stochastic Oscillator ChartOKYO Pharma Ltd ADR Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of OKYO Pharma Ltd ADR. The current cci is 137.57.

The long score for the Commodity Channel Index (CCI) is 1/1.
The longshort score for the Commodity Channel Index (CCI) is 1/(-1 +1).

  • CCI > 100: The CCI is above 100, it indicates that the price is significantly above its average, suggesting a potential overbought condition. +1
OKYO Pharma Ltd ADR Daily Commodity Channel Index (CCI) ChartOKYO Pharma Ltd ADR Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of OKYO Pharma Ltd ADR. The current cmo is 24.42.

The long score for the Chande Momentum Oscillator (CMO) is 1/1.
The longshort score for the Chande Momentum Oscillator (CMO) is 1/(-1 +1).

  • CMO > 0: The CMO is above 0, the momentum of the price is positive, indicating a potential uptrend in the price. +1
OKYO Pharma Ltd ADR Daily Chande Momentum Oscillator (CMO) ChartOKYO Pharma Ltd ADR Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of OKYO Pharma Ltd ADR. The current willr is -14.12429379.

The long score for the Williams %R is 1/1.
The longshort score for the Williams %R is 1/(-1 +1).

  • WILLR > -20: The Williams %R is above -20. This indicates that the price is in overbought territory, suggesting a potential price correction or trend reversal to the downside. +1
OKYO Pharma Ltd ADR Daily Williams %R ChartOKYO Pharma Ltd ADR Daily Williams %R Chart
3rd party ad coffee SUPPORTERis ad-free.

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of OKYO Pharma Ltd ADR.

OKYO Pharma Ltd ADR Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of OKYO Pharma Ltd ADR. The current atr is 0.18774573.

OKYO Pharma Ltd ADR Daily Average True Range (ATR) ChartOKYO Pharma Ltd ADR Daily Average True Range (ATR) Chart
3rd party ad coffee SUPPORTERis ad-free.

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of OKYO Pharma Ltd ADR. The current obv is 22,505,010.

OKYO Pharma Ltd ADR Daily On-Balance Volume (OBV) ChartOKYO Pharma Ltd ADR Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of OKYO Pharma Ltd ADR. The current mfi is 62.94.

The long score for the Money Flow Index (MFI) is 1/2.
The longshort score for the Money Flow Index (MFI) is 1/(-2 +2).

  • MFI > 50: +1
OKYO Pharma Ltd ADR Daily Money Flow Index (MFI) ChartOKYO Pharma Ltd ADR Daily Money Flow Index (MFI) Chart
3rd party ad coffee SUPPORTERis ad-free.

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for OKYO Pharma Ltd ADR.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2025-06-05STOCH LONG EXITThe %K line crosses below the %D line.
2025-06-06STOCH SHORT EXITThe %K line crosses above the %D line.
2025-06-09CCI LONG ENTRY SHORT CLOSE100 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-06-10STOCH LONG EXITThe %K line crosses below the %D line.
2025-06-11BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-06-12STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-06-13ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-06-16RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-06-17SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2025-06-20STOCH SHORT EXITThe %K line crosses above the %D line.
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2025-06-23MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2025-06-25STOCH SHORT EXITThe %K line crosses above the %D line.
2025-06-27STOCH LONG EXITThe %K line crosses below the %D line.
2025-06-30STOCH SHORT EXITThe %K line crosses above the %D line.
2025-07-02MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-07-07STOCH LONG EXITThe %K line crosses below the %D line.
2025-07-08STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2025-07-09STOCH LONG EXITThe %K line crosses below the %D line.
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2025-07-11MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2025-07-14MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-07-15CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2025-07-16STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2025-07-17MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2025-07-18WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2025-07-21STOCH LONG EXITThe %K line crosses below the %D line.
2025-07-23STOCH SHORT EXITThe %K line crosses above the %D line.
2025-07-24STOCH LONG EXITThe %K line crosses below the %D line.
2025-07-28CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-07-29SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2025-07-31STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2025-08-01SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2025-08-05MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2025-08-07STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2025-08-08MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2025-08-11STOCH LONG EXITThe %K line crosses below the %D line.
2025-08-12MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2025-08-13MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-08-18CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-08-20STOCH SHORT EXITThe %K line crosses above the %D line.
2025-08-21STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-08-25STOCH SHORT EXITThe %K line crosses above the %D line.
2025-08-26STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-08-29STOCH SHORT EXITThe %K line crosses above the %D line.
2025-09-03STOCH LONG EXITThe %K line crosses below the %D line.
2025-09-05STOCH SHORT EXITThe %K line crosses above the %D line.
2025-09-08STOCH LONG EXITThe %K line crosses below the %D line.
2025-09-11SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2025-09-12WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-09-15SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2025-09-17STOCH SHORT EXITThe %K line crosses above the %D line.
2025-09-18STOCH LONG EXITThe %K line crosses below the %D line.
2025-09-19STOCH SHORT EXITThe %K line crosses above the %D line.
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2025-09-22MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
RSI LONG ENTRY SHORT CLOSE30 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-09-23CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-09-24STOCH LONG EXITThe %K line crosses below the %D line.
2025-09-25STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2025-09-26CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-09-29SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-10-01STOCH SHORT EXITThe %K line crosses above the %D line.
2025-10-02STOCH LONG EXITThe %K line crosses below the %D line.
2025-10-03STOCH SHORT EXITThe %K line crosses above the %D line.
2025-10-07STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2025-10-08DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-10-09STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-10-10DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-10-14CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-10-15STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2025-10-17DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2025-10-20SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-10-21STOCH LONG EXITThe %K line crosses below the %D line.
2025-10-24STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside

6.3. Candlestick Patterns

OKYO Pharma Ltd ADR Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of OKYO Pharma Ltd ADR based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5058.276
Ma 20Greater thanMa 502.117
Ma 50Greater thanMa 1002.198
Ma 100Greater thanMa 2002.428
OpenGreater thanClose2.280
Total2/5 (40.0%)
Penke
Good job! You gained 25 XP and 0   0   10 . What's next:
  • Share my analysis of OKYO Pharma Ltd ADR with someone you think should read this too:
  • Are you bullish or bearish on OKYO Pharma Ltd ADR? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about OKYO Pharma Ltd ADR? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about OKYO Pharma Ltd ADR

I send you an email if I find something interesting about OKYO Pharma Ltd ADR.


Comments

How you think about this?

Leave a comment

Stay informed about OKYO Pharma Ltd ADR.

Receive notifications about OKYO Pharma Ltd ADR in your mailbox!

3rd party ad coffee SUPPORTERis ad-free.